Patents-Review.com
🔗 Permalink
Assignee profile:

NEURALSTEM, INC.

City:

Germantown, Maryland

Country:

United States

Published Applications:

12

Last publication date:

2021-04-15

Patent Grants:

9

Last grant date:

2019-09-17

Top Inventors for applications by NEURALSTEM, INC.

These are the the leading inventors for applications assigned to NEURALSTEM, INC.:

Recent patent applications by NEURALSTEM, INC.

NEURALSTEM, INC. based in Germantown, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-04-15
US20210106579A1
Human necessities

AMELIORATION OF COGNITIVE AND MOTOR DEFICITS ASSOCIATED WITH ALZHEIMER'S

 #2 | 2019-05-16
US20190142829A1
Human necessities

AMELIORATION OF ANGELMAN'S SYNDROME DEFICIENCIES

 #3 | 2018-08-16 ✅ Patent 10,413,534 granted on 2019-09-17
US20180228787A1
Human necessities

Amelioration of certain deficiencies due to stroke

 #4 | 2018-04-19
US20180104240A1
Human necessities

AMELIORATION OF RADIATION-INDUCED COGNITIVE DYSFUNCTION

 #5 | 2018-03-15 ✅ Patent 10,322,115 granted on 2019-06-18
US20180071267A1
Human necessities

Amelioration of neural deficits associated with diabetes

 #6 | 2017-11-09 ✅ Patent 10,702,555 granted on 2020-07-07
US20170319625A1
Human necessities

Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof

 #7 | 2016-05-05 ✅ Patent 9,750,769 granted on 2017-09-05
US20160120942A1
Human necessities

Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof

 #8 | 2016-03-31 ✅ Patent 9,481,649 granted on 2016-11-01
US20160090358A1
Chemistry; metallurgy

Synthesis of a neurostimulative piperazine

 #9 | 2015-12-17 ✅ Patent 9,572,807 granted on 2017-02-21
US20150359792A1
Human necessities

Protocols for treatment of major depressive disorder (MDD)

 #10 | 2014-05-29 ✅ Patent 8,846,914 granted on 2014-09-30
US20140147424A1
Chemistry; metallurgy

Compositions to effect neuronal growth

 #11 | 2013-01-03 ✅ Patent 9,278,933 granted on 2016-03-08
US20130005974A1
Chemistry; metallurgy

Synthesis of a neurostimulative piperazine

 #12 | 2012-07-12 ✅ Patent 9,540,611 granted on 2017-01-10
US20120177612A1
Chemistry; metallurgy

Methods for treating and/or reversing neurodegenerative diseases and/or disorders

Also check out NEURALSTEM, INC.'s (Germantown, United States) applicant profile with 8 patent applications submitted.

AssigneeID:

106743 ⎘